HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: ClickStick Electric Deodorant; Olay On Air Pollution; Cetaphil For Eczema

This article was originally published in The Rose Sheet

Executive Summary

“Smart” ClickStick deodorant applicator can help consumers save money, limit aluminum exposure and minimize environmental impact, the Princeton, N.J.-based startup says. More news in brief.

You may also be interested in...



New Products In Brief

Nestle’s Galderma unit continues to invest in Cetaphil, launching a line of baby products. More product launch news.

Cosmetics Legislative Plans Vie In Congress

Rep. Frank Pallone, D-N.J., introduces the Cosmetic Safety Enhancement Act of 2012 before March 27th’s Energy and Commerce hearing on cosmetics regulation. Representatives Jan Schakowsky and Ed Markey push for their Safe Cosmetics Act of 2011, while Rep. Leonard Lance, R-N.J., intends to introduce his own cosmetics plan.

Warning Letter Close-Outs – March 2020

The US FDA released five device-related close-out letters in March.

Related Companies

UsernamePublicRestriction

Register

RS019305

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel